In glioblastoma, elevated FA pathway activity, particularly through UBE2T‐dependent regulation, has been associated with enhanced repair capacity and reduced responsiveness to DNA‐damaging therapies, positioning this pathway as a potential target to overcome chemoresistance [9, 10, 11]. Here, UBE2T is linked to glioblastoma.